Efficacy and Safety of Everolimus in Liver Transplant Recipients of Living Donor Liver Transplants
Status:
Completed
Trial end date:
2018-04-21
Target enrollment:
Participant gender:
Summary
The purpose of this trial was to demonstrate the efficacy and safety of everolimus in
combination with reduced tacrolimus, compared to tacrolimus control, in living donor liver
transplant recipients.